Condition: Prostate Cancer · Sponsor: UNICANCER
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known which dose of radiation therapy is more effective in treating patients with prostate cancer. PURPOSE: This randomized phase III trial is comparing two radiation therapy regimens in treating patients with prostate cancer receiving hormone therapy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Institut de Cancérologie de l'Ouest Paul Papin | Angers, France | — |
| Institut Bergonie | Bordeaux, France | — |
| Centre Francois Baclesse | Caen, France | — |
| Centre hospitalier Métropole Savoie | Chambéry, France | — |
| Clinique Léonard de Vinci | Chambray-lès-Tours, France | — |
| CHU Henri Mondor | Créteil, France | — |
| Centre Léon Bérard | Lyon, France | — |
| Hopital La Timone | Marseille, France | — |
| Centre de Cancérologie du Grand Montpellier | Montpellier, France | — |
| Centre Val D'Aurelle | Montpellier, France | — |
| Centre Azureen de Cancerologie | Mougins, France | — |
| Chr Orleans | Orléans, France | — |
+ 13 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.